JP2023510778A5 - - Google Patents
Info
- Publication number
- JP2023510778A5 JP2023510778A5 JP2022542118A JP2022542118A JP2023510778A5 JP 2023510778 A5 JP2023510778 A5 JP 2023510778A5 JP 2022542118 A JP2022542118 A JP 2022542118A JP 2022542118 A JP2022542118 A JP 2022542118A JP 2023510778 A5 JP2023510778 A5 JP 2023510778A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- alkyl groups
- optionally
- membered
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025160231A JP2026016394A (ja) | 2020-01-09 | 2025-09-26 | ナノマテリアル |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062958876P | 2020-01-09 | 2020-01-09 | |
| US62/958,876 | 2020-01-09 | ||
| PCT/US2021/012282 WO2021141969A1 (en) | 2020-01-09 | 2021-01-06 | Nanomaterials |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025160231A Division JP2026016394A (ja) | 2020-01-09 | 2025-09-26 | ナノマテリアル |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023510778A JP2023510778A (ja) | 2023-03-15 |
| JP2023510778A5 true JP2023510778A5 (enExample) | 2024-01-17 |
| JP7791822B2 JP7791822B2 (ja) | 2025-12-24 |
Family
ID=76788721
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542118A Active JP7791822B2 (ja) | 2020-01-09 | 2021-01-06 | ナノマテリアル |
| JP2025160231A Pending JP2026016394A (ja) | 2020-01-09 | 2025-09-26 | ナノマテリアル |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025160231A Pending JP2026016394A (ja) | 2020-01-09 | 2025-09-26 | ナノマテリアル |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12435035B2 (enExample) |
| EP (1) | EP4103542A4 (enExample) |
| JP (2) | JP7791822B2 (enExample) |
| KR (1) | KR20220123536A (enExample) |
| CN (2) | CN119684140A (enExample) |
| AU (1) | AU2021205837A1 (enExample) |
| BR (1) | BR112022013599A2 (enExample) |
| CA (1) | CA3163161A1 (enExample) |
| IL (1) | IL294318A (enExample) |
| MX (1) | MX2022008455A (enExample) |
| WO (1) | WO2021141969A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3145913A1 (en) | 2019-07-29 | 2021-02-04 | James Everett Dahlman | Nanomaterials containing constrained lipids and uses thereof |
| IL294318A (en) | 2020-01-09 | 2022-08-01 | Guide Therapeutics Llc | Nanomaterials |
| KR20230041726A (ko) | 2020-07-15 | 2023-03-24 | 더블유.엘. 고어 앤드 어소시에이트스, 인코포레이티드 | 필터 매체의 재생 및 연도 가스의 세정 방법 |
| JP2023549011A (ja) | 2020-09-15 | 2023-11-22 | ヴァーヴ・セラピューティクス，インコーポレーテッド | 遺伝子編集のための脂質製剤 |
| EP4228658A4 (en) | 2020-10-14 | 2025-02-19 | George Mason Research Foundation, Inc. | IONIZABLE LIPIDS AND METHODS FOR THE PRODUCTION AND USE THEREOF |
| EP4262819A4 (en) * | 2020-12-21 | 2024-12-04 | Beam Therapeutics Inc. | NANOMATERIALS WITH ESTER-BOUND ACETALS |
| CN116761888A (zh) | 2021-01-20 | 2023-09-15 | 比姆医疗股份有限公司 | 纳米材料 |
| EP4281080A4 (en) * | 2021-01-20 | 2025-09-24 | Beam Therapeutics Inc | NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT |
| US20240180954A1 (en) * | 2021-02-04 | 2024-06-06 | Shionogi & Co., Ltd. | Cationic lipid |
| JP2024536406A (ja) * | 2021-10-08 | 2024-10-04 | スージョウ・アボジェン・バイオサイエンシズ・カンパニー・リミテッド | 脂質化合物及び脂質ナノ粒子組成物 |
| CA3248846A1 (en) * | 2022-01-17 | 2023-07-20 | Sanofi | Lipid Compounds and Their Uses |
| WO2023230601A1 (en) | 2022-05-27 | 2023-11-30 | Beam Therapeutics Inc. | Identification of nanoparticles for preferential tissue or cell targeting |
| CA3260437A1 (en) | 2022-07-20 | 2024-01-25 | Beam Therapeutics Inc. | NANOMATERIALS INCLUDING TRIOLS |
| WO2024199282A1 (zh) * | 2023-03-28 | 2024-10-03 | 苏州艾博生物科技有限公司 | 脂质化合物和脂质纳米颗粒组合物 |
| AU2024279278A1 (en) | 2023-05-31 | 2025-12-18 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025038864A1 (en) * | 2023-08-16 | 2025-02-20 | Beam Therapeutics Inc. | Ionizable lipids with linear head groups |
| CN119490447A (zh) * | 2023-08-17 | 2025-02-21 | 苏州星核迪赛生物技术有限公司 | 药物递送材料及其应用 |
| WO2025166314A1 (en) * | 2024-02-02 | 2025-08-07 | Tessera Therapeutics, Inc. | Ex vivo delivery of lipid nanoparticles for delivery of gene modifying systems to t cells |
| WO2025212851A2 (en) | 2024-04-03 | 2025-10-09 | Orbital Therapeutics, Inc. | mRNA COMPOSITIONS AND USES THEREOF IN VARICELLA ZOSTER VIRUS VACCINES |
| WO2025259931A1 (en) | 2024-06-14 | 2025-12-18 | Orbital Therapeutics, Inc. | Compositions and methods for rna circularization |
| WO2026006203A2 (en) | 2024-06-24 | 2026-01-02 | Orbital Therapeutics, Inc. | Compositions and methods for making circular rna |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
| WO2026006687A1 (en) | 2024-06-28 | 2026-01-02 | Orbital Therapeutics, Inc. | Circular rna compositions and uses thereof for diseases caused by varicella-zoster virus |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL257307A (enExample) | 1959-10-28 | |||
| US3686238A (en) | 1970-01-19 | 1972-08-22 | Syntex Corp | Glycerol esterified with 2-naphthyl-acetic acids and fatty acids |
| US20030083272A1 (en) | 1997-09-19 | 2003-05-01 | Lahive & Cockfield, Llp | Sense mrna therapy |
| US6670499B1 (en) | 1999-11-08 | 2003-12-30 | Daicel Chemical Industries, Ltd. | Adamantane derivatives and processes for the preparation thereof |
| CA2429814C (en) | 2000-12-01 | 2014-02-18 | Thomas Tuschl | Rna interference mediating small rna molecules |
| US20040077888A1 (en) | 2002-05-31 | 2004-04-22 | The Regents Of The University Of California | Polyamine-mediated transfection |
| JP2005181734A (ja) | 2003-12-19 | 2005-07-07 | Fuji Photo Film Co Ltd | 画像記録材料 |
| DE102007029471A1 (de) | 2007-06-20 | 2008-12-24 | Novosom Ag | Neue fakultativ kationische Sterole |
| CA2721333C (en) | 2008-04-15 | 2020-12-01 | Protiva Biotherapeutics, Inc. | Novel lipid formulations for nucleic acid delivery |
| KR20190039347A (ko) | 2010-06-03 | 2019-04-10 | 알닐람 파마슈티칼스 인코포레이티드 | 활성제의 전달을 위한 생분해성 지질 |
| PE20181541A1 (es) | 2011-10-27 | 2018-09-26 | Massachusetts Inst Technology | Derivados de aminoacidos funcionalizados en la terminal n capaces de formar microesferas encapsuladoras de farmaco |
| WO2013086354A1 (en) | 2011-12-07 | 2013-06-13 | Alnylam Pharmaceuticals, Inc. | Biodegradable lipids for the delivery of active agents |
| CN107879960B (zh) | 2013-03-08 | 2021-06-22 | 诺华股份有限公司 | 用于传递活性成分的脂质和脂质组合物 |
| US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
| EP3083556B1 (en) | 2013-12-19 | 2019-12-25 | Novartis AG | Lipids and lipid compositions for the delivery of active agents |
| US10426737B2 (en) | 2013-12-19 | 2019-10-01 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| US10125092B2 (en) | 2014-09-05 | 2018-11-13 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| ES2880103T3 (es) | 2015-05-21 | 2021-11-23 | Ohio State Innovation Foundation | Derivados de benceno-1, 3, 5-tricarboxamida y usos de los mismos |
| JP6948313B6 (ja) | 2015-09-17 | 2022-01-14 | モデルナティエックス インコーポレイテッド | 治療剤の細胞内送達のための化合物および組成物 |
| IL310721B2 (en) | 2015-10-23 | 2025-11-01 | Harvard College | Nucleobase editors and uses thereof |
| HRP20230209T1 (hr) * | 2015-10-28 | 2023-04-14 | Acuitas Therapeutics Inc. | Novi lipidi i lipidne formulacije nanočestica za isporuku nukleinskih kiselina |
| LT3436077T (lt) | 2016-03-30 | 2025-06-25 | Intellia Therapeutics, Inc. | Lipidų nanodalelių vaisto formos, skirtos crispr/cas komponentams |
| MY206271A (en) | 2016-07-11 | 2024-12-06 | Opko Biologics Ltd | Long-acting coagulation factor vii and methods of producing same |
| CN110214183A (zh) | 2016-08-03 | 2019-09-06 | 哈佛大学的校长及成员们 | 腺苷核碱基编辑器及其用途 |
| EP4186888B1 (en) * | 2017-03-15 | 2025-11-26 | ModernaTX, Inc. | Compound and compositions for intracellular delivery of therapeutic agents |
| BR112019025104A2 (pt) | 2017-05-30 | 2020-06-23 | Glaxosmithkline Biologicals S.A. | Método de fabricar um sistema de entrega não viral, sistema de entrega não viral, e, composição |
| CN120682290A (zh) | 2017-07-04 | 2025-09-23 | 尹图赛利有限公司 | 包含可裂解接头的化合物及其用途 |
| CA3081414A1 (en) | 2017-10-30 | 2019-05-09 | Georgia Tech Research Corporation | Multiplexed analysis of materials for tissue delivery |
| US11622942B2 (en) | 2017-11-14 | 2023-04-11 | Ohio State Innovation Foundation | Benzene-1,3,5-tricarboxamide derived ester lipids and uses thereof |
| EP3727362A4 (en) | 2017-12-19 | 2021-10-06 | PureTech LYT, Inc. | MYCOPHENOLIC ACID LIPID PRODRUGS AND THEIR USES |
| TWI894123B (zh) | 2017-12-27 | 2025-08-21 | 日商武田藥品工業有限公司 | 含核酸之脂質奈米粒子及其用途 |
| CN112955099B (zh) | 2018-07-27 | 2024-04-26 | 雷森斯医疗有限公司 | 医疗冷却装置和使用其的冷却方法 |
| CA3107481A1 (en) | 2018-08-02 | 2020-02-06 | Puretech Lyt, Inc. | Lipid prodrugs of pregnane neurosteroids and uses thereof |
| EP3842538A4 (en) | 2018-08-10 | 2022-06-08 | Kyoto University | METHOD OF TRANSFECTION INTO CARDIOMYOCYTES USING CATIONIC LIPID |
| US20220009878A1 (en) | 2018-10-02 | 2022-01-13 | Intellia Therapeutics, Inc. | Ionizable amine lipids |
| BR112021010853A2 (pt) | 2018-12-05 | 2021-08-31 | Intellia Therapeutics, Inc. | Lipídios de amina modificados |
| CN119700703A (zh) | 2019-01-17 | 2025-03-28 | 佐治亚技术研究公司 | 含有氧化的胆固醇的药物递送系统 |
| US11845874B2 (en) | 2019-01-24 | 2023-12-19 | Agfa Nv | Radiation curable inkjet inks for interior decoration |
| JP7693552B2 (ja) | 2019-02-13 | 2025-06-17 | ビーム セラピューティクス インク． | アデノシンデアミナーゼ塩基エディターおよびそれを用いて標的配列中の核酸塩基を改変する方法 |
| CA3130349A1 (en) | 2019-02-28 | 2020-09-03 | Puretech Lyt, Inc. | Lipid prodrugs of jak inhibitors and uses thereof |
| WO2020176856A1 (en) | 2019-02-28 | 2020-09-03 | Puretech Lyt, Inc. | Lipid prodrugs of glucocorticoids and uses thereof |
| WO2020176868A1 (en) | 2019-02-28 | 2020-09-03 | Puretech Lyt, Inc. | Lipid prodrugs of btk inhibitors and uses thereof |
| CN114127044A (zh) * | 2019-04-25 | 2022-03-01 | 英特利亚治疗股份有限公司 | 可电离的胺类脂质和脂质纳米颗粒 |
| JP2022536112A (ja) | 2019-06-05 | 2022-08-12 | ガイド セラピューティクス，インコーポレーテッド | 組織送達のための材料の分析 |
| WO2020246581A1 (ja) | 2019-06-07 | 2020-12-10 | 富士フイルム株式会社 | 脂質組成物 |
| WO2021021636A1 (en) | 2019-07-29 | 2021-02-04 | Georgia Tech Research Corporation | Oligonucleotide antagonists for rna guided genome editing |
| CA3145913A1 (en) | 2019-07-29 | 2021-02-04 | James Everett Dahlman | Nanomaterials containing constrained lipids and uses thereof |
| CN114901799A (zh) | 2019-10-21 | 2022-08-12 | 弗拉斯沃克斯有限责任公司 | 用于细胞培养的系统和方法 |
| KR20220113737A (ko) | 2019-12-06 | 2022-08-16 | 가이드 테라퓨틱스 엘엘씨 | 나노물질 |
| IL294318A (en) | 2020-01-09 | 2022-08-01 | Guide Therapeutics Llc | Nanomaterials |
| JP2024503976A (ja) | 2020-12-21 | 2024-01-30 | ビーム セラピューティクス インク． | アセタールを含むナノ材料 |
| EP4262818A4 (en) | 2020-12-21 | 2025-03-26 | Beam Therapeutics Inc. | NANOMATERIALS WITH CARBONATES |
| EP4262819A4 (en) | 2020-12-21 | 2024-12-04 | Beam Therapeutics Inc. | NANOMATERIALS WITH ESTER-BOUND ACETALS |
| EP4281080A4 (en) | 2021-01-20 | 2025-09-24 | Beam Therapeutics Inc | NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT |
| CN116761888A (zh) | 2021-01-20 | 2023-09-15 | 比姆医疗股份有限公司 | 纳米材料 |
| JP2024503441A (ja) | 2021-01-20 | 2024-01-25 | ビーム セラピューティクス インク． | イオン化可能な脂質を含むナノ材料 |
| CA3203784A1 (en) | 2021-01-20 | 2022-07-28 | Beam Therapeutics Inc. | Ionizable lipids for nanomaterials |
| EP4351651A1 (en) | 2021-05-28 | 2024-04-17 | Renagade Therapeutics Management Inc. | Lipid nanoparticles and methods of use thereof |
| JP2024536406A (ja) | 2021-10-08 | 2024-10-04 | スージョウ・アボジェン・バイオサイエンシズ・カンパニー・リミテッド | 脂質化合物及び脂質ナノ粒子組成物 |
| CA3241488A1 (en) | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Ionizable amine lipids and lipid nanoparticles |
| EP4452925A1 (en) | 2021-12-20 | 2024-10-30 | Beam Therapeutics Inc. | Nanomaterial comprising diamines |
| EP4452942A1 (en) | 2021-12-20 | 2024-10-30 | Beam Therapeutics Inc. | Nanomaterials comprising disulfides |
| WO2023121970A1 (en) | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Ionizable amine and ester lipids and lipid nanoparticles |
| JP2025500824A (ja) | 2021-12-20 | 2025-01-15 | ビーム セラピューティクス インク． | 四価脂質化合物を含むナノ材料 |
| CA3260437A1 (en) | 2022-07-20 | 2024-01-25 | Beam Therapeutics Inc. | NANOMATERIALS INCLUDING TRIOLS |
-
2021
- 2021-01-06 IL IL294318A patent/IL294318A/en unknown
- 2021-01-06 KR KR1020227026151A patent/KR20220123536A/ko not_active Ceased
- 2021-01-06 MX MX2022008455A patent/MX2022008455A/es unknown
- 2021-01-06 US US17/142,595 patent/US12435035B2/en active Active
- 2021-01-06 EP EP21738179.7A patent/EP4103542A4/en active Pending
- 2021-01-06 WO PCT/US2021/012282 patent/WO2021141969A1/en not_active Ceased
- 2021-01-06 AU AU2021205837A patent/AU2021205837A1/en active Pending
- 2021-01-06 CN CN202411119983.0A patent/CN119684140A/zh active Pending
- 2021-01-06 BR BR112022013599A patent/BR112022013599A2/pt unknown
- 2021-01-06 CA CA3163161A patent/CA3163161A1/en active Pending
- 2021-01-06 CN CN202180016840.5A patent/CN115175894B/zh active Active
- 2021-01-06 JP JP2022542118A patent/JP7791822B2/ja active Active
-
2025
- 2025-09-03 US US19/317,946 patent/US20260001838A1/en active Pending
- 2025-09-26 JP JP2025160231A patent/JP2026016394A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023510778A5 (enExample) | ||
| JP2023505316A5 (enExample) | ||
| JP2025181861A5 (enExample) | ||
| AU2023200568C1 (en) | Novel lipids and compositions for the delivery of therapeutics | |
| CA2767129C (en) | Compositions and methods for silencing apolipoprotein b | |
| CN104004018B (zh) | 具有含氮脂环式骨架的单链核酸分子 | |
| CN111343994B (zh) | 用于抑制血管生成素-样3 (ANGPTL3)的表达的RNAi剂和组合物以及使用方法 | |
| AU2022268351A1 (en) | Di-aliphatic substituted pegylated lipids | |
| CN109562188B (zh) | 与三价糖缀合物连接的核酸 | |
| JP7748500B2 (ja) | トリループを含む二本鎖核酸インヒビター分子 | |
| ES3017428T3 (en) | Ionizable cationic lipids for lipid nanoparticles | |
| Nawrot et al. | Chemical and structural diversity of siRNA molecules | |
| JP6422961B2 (ja) | 改善された高効率ナノ粒子型オリゴヌクレオチド構造体およびその製造方法 | |
| CA2685127A1 (en) | Glycoconjugates of rna interference agents | |
| RS58077B1 (sr) | Trialkil katjonski lipidi i postupci njihove primene | |
| RU2020135289A (ru) | Применение ингибиторов fubp1 для лечения инфекции вирусом гепатита в | |
| WO2019074110A1 (ja) | 一本鎖核酸分子およびその製造方法 | |
| KR20220004675A (ko) | 단축 센스 가닥을 갖는 이중 가닥 핵산 억제제 분자 | |
| JP2024508780A5 (enExample) | ||
| JP2024509906A5 (enExample) | ||
| TWI871840B (zh) | 合成4'-磷酸鹽類似物核苷酸亞磷醯胺之方法 | |
| RU2026104839A (ru) | Мультивалентные комплексы, несущие полезную нагрузку, и их применение | |
| KR20260042246A (ko) | 다가 카고 함유 복합체 및 이의 용도 | |
| RU2020118025A (ru) | Нуклеиновая кислота, композиция и конъюгат, содержащие ее, а также способ их получения и применения | |
| ES2368300B1 (es) | Derivados lipofílicos de ácidos nucleicos. |